Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The "Primary Health Care Market - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. Primary health care is essential in...
-
Singapore, Dec. 12, 2025 (GLOBE NEWSWIRE) -- iOThree Limited (“iO3” or the “Company”) (Nasdaq: IOTR), a pioneering provider of digital solutions for the maritime industry, today issued the...
-
The Company is actively engaging with policy leaders in the U.S. and has been involved in ongoing constructive proposals regarding automotive policy, particularly involving the EV sector and FX’s new...
-
Places limitées – réservez votre place dès aujourd’hui pour le sommet inaugural sur la santé des femmes. Tarif préférentiel jusqu'au 23 janvier TORONTO, 11 déc. 2025 (GLOBE NEWSWIRE) -- Les...
-
Dublin, Dec. 11, 2025 (GLOBE NEWSWIRE) -- The "Non-Opioid Therapeutics Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. This market research report...
-
Exploring Growth Trends and Strategic Drivers in Medical Equipment Maintenance Across Global Markets
Dublin, Dec. 11, 2025 (GLOBE NEWSWIRE) -- The "Medical Equipment Repair & Maintenance Services Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. The...
-
Issued on behalf of Aleen Inc. VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Last month marked a major turning point as Google launched Gemini...
-
The cell & gene therapy market is a rapidly growing sector that involves the use of cellular and genetic materials to treat various diseases and condition.
-
SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic...
-
TOKYO and CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...